364 related articles for article (PubMed ID: 19924695)
1. The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease.
McNaught KS; Jnobaptiste R; Jackson T; Jengelley TA
Synapse; 2010 Mar; 64(3):241-50. PubMed ID: 19924695
[TBL] [Abstract][Full Text] [Related]
2. Altered proteasomal function in sporadic Parkinson's disease.
McNaught KS; Belizaire R; Isacson O; Jenner P; Olanow CW
Exp Neurol; 2003 Jan; 179(1):38-46. PubMed ID: 12504866
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of proteasome activity sensitizes dopamine neurons to protein alterations and oxidative stress.
Mytilineou C; McNaught KS; Shashidharan P; Yabut J; Baptiste RJ; Parnandi A; Olanow CW
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1237-51. PubMed ID: 15480836
[TBL] [Abstract][Full Text] [Related]
4. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Bukhatwa S; Zeng BY; Rose S; Jenner P
Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003
[TBL] [Abstract][Full Text] [Related]
5. Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease.
McNaught KS; Belizaire R; Jenner P; Olanow CW; Isacson O
Neurosci Lett; 2002 Jul; 326(3):155-8. PubMed ID: 12095645
[TBL] [Abstract][Full Text] [Related]
6. Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease.
Xie W; Li X; Li C; Zhu W; Jankovic J; Le W
J Neurochem; 2010 Oct; 115(1):188-99. PubMed ID: 20649845
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70.
Mandel S; Grunblatt E; Riederer P; Amariglio N; Jacob-Hirsch J; Rechavi G; Youdim MB
Ann N Y Acad Sci; 2005 Aug; 1053():356-75. PubMed ID: 16179542
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of proteasomal inhibition and apoptosis induced in N27 mesencephalic cells by dopamine and MG132.
Zafar KS; Inayat-Hussain SH; Ross D
J Neurochem; 2007 Aug; 102(3):913-21. PubMed ID: 17504267
[TBL] [Abstract][Full Text] [Related]
9. Multiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo.
Du Y; Li X; Yang D; Zhang X; Chen S; Huang K; Le W
Exp Biol Med (Maywood); 2008 Jul; 233(7):881-90. PubMed ID: 18445767
[TBL] [Abstract][Full Text] [Related]
10. Proteasome inhibitor MG-132 induces dopaminergic degeneration in cell culture and animal models.
Sun F; Anantharam V; Zhang D; Latchoumycandane C; Kanthasamy A; Kanthasamy AG
Neurotoxicology; 2006 Sep; 27(5):807-15. PubMed ID: 16870259
[TBL] [Abstract][Full Text] [Related]
11. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
[TBL] [Abstract][Full Text] [Related]
12. Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration.
Zhu W; Li X; Xie W; Luo F; Kaur D; Andersen JK; Jankovic J; Le W
Neurobiol Dis; 2010 Feb; 37(2):307-13. PubMed ID: 19818853
[TBL] [Abstract][Full Text] [Related]
13. [Content of chaperon Hsp70 in dopaminergic neurons of the black substance increases in proteasome dysfunstion].
Pastukhov IuF; Ekimova IV; Guzhova IV; Romanova IV; Artiukhina ZE
Ross Fiziol Zh Im I M Sechenova; 2011 Jul; 97(7):649-60. PubMed ID: 21961290
[TBL] [Abstract][Full Text] [Related]
14. Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures.
McNaught KS; Mytilineou C; Jnobaptiste R; Yabut J; Shashidharan P; Jennert P; Olanow CW
J Neurochem; 2002 Apr; 81(2):301-6. PubMed ID: 12064477
[TBL] [Abstract][Full Text] [Related]
15. [Sleep changes during degeneration of neurons in the substantia nigra induced by inhibitor of proteasomes lactacystin in rats].
Pastukhov IuF; Chesnokova AIu; Iakimchuk AA; Ekimova IV; Romanova IV; Khudik KA
Ross Fiziol Zh Im I M Sechenova; 2010 Dec; 96(12):1190-202. PubMed ID: 21473106
[TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibition causes nigral degeneration with inclusion bodies in rats.
McNaught KS; Björklund LM; Belizaire R; Isacson O; Jenner P; Olanow CW
Neuroreport; 2002 Aug; 13(11):1437-41. PubMed ID: 12167769
[TBL] [Abstract][Full Text] [Related]
17. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.
Testa CM; Sherer TB; Greenamyre JT
Brain Res Mol Brain Res; 2005 Mar; 134(1):109-18. PubMed ID: 15790535
[TBL] [Abstract][Full Text] [Related]
18. MPTP treatment of common marmosets impairs proteasomal enzyme activity and decreases expression of structural and regulatory elements of the 26S proteasome.
Zeng BY; Iravani MM; Lin ST; Irifune M; Kuoppamäki M; Al-Barghouthy G; Smith L; Jackson MJ; Rose S; Medhurst AD; Jenner P
Eur J Neurosci; 2006 Apr; 23(7):1766-74. PubMed ID: 16623833
[TBL] [Abstract][Full Text] [Related]
19. Aggresome-related biogenesis of Lewy bodies.
McNaught KS; Shashidharan P; Perl DP; Jenner P; Olanow CW
Eur J Neurosci; 2002 Dec; 16(11):2136-48. PubMed ID: 12473081
[TBL] [Abstract][Full Text] [Related]
20. c-Jun N-terminal kinase mediates lactacystin-induced dopamine neuron degeneration.
Li X; Du Y; Fan X; Yang D; Luo G; Le W
J Neuropathol Exp Neurol; 2008 Oct; 67(10):933-44. PubMed ID: 18800014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
